Journal of Global Infectious Diseases

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 10  |  Issue : 3  |  Page : 125--128

Treatment outcomes associated with multidrug-resistant tuberculosis


Nitin Gupta, Pankaj Jorwal 
 Department of Medicine, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Dr. Pankaj Jorwal
Department of Medicine, 3rd Floor, Teaching Block, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
India

Background: Developing countries like India are heavily burdened with multidrug resistant tuberculosis (MDR-TB). Materials and Methods: A retrospective study was carried out at the directly observed treatment short course chemotherapy plus site in our tertiary care center (All India Institute of Medical Sciences, New Delhi) where records of all patients enrolled between 2009 and 2013 were reviewed. The aim of this study was to calculate the frequency of predefined outcomes in these patients receiving standardized treatment for MDR-TB. Results: Out of a total of 819 patients, the frequency of outcomes in these patients was as follows: Cured (n = 415, 52%), default (n = 199, 24%), death (n = 130, 16%), switched to category V (n = 27, 3%), transferred out (n = 12, 1%), treatment failure (n = 13, 1%), and treatment completed (n = 23, 3%). Conclusion: The modest cure rate in concordance with other Indian studies highlights the need for continuing efforts to fight the menace of MDR-TB.


How to cite this article:
Gupta N, Jorwal P. Treatment outcomes associated with multidrug-resistant tuberculosis.J Global Infect Dis 2018;10:125-128


How to cite this URL:
Gupta N, Jorwal P. Treatment outcomes associated with multidrug-resistant tuberculosis. J Global Infect Dis [serial online] 2018 [cited 2021 May 6 ];10:125-128
Available from: https://www.jgid.org/article.asp?issn=0974-777X;year=2018;volume=10;issue=3;spage=125;epage=128;aulast=Gupta;type=0